Clinical Trial Update: AMSC for Reducing Anastomotic Stenosis in Primary Arteriovenous Anastomoses [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating autologous mesenchymal stem cells (AMSC) to reduce anastomotic stenosis in primary arteriovenous anastomoses for end-stage ren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Drugs mentioned

• AMSC (Autologous Mesenchymal Stem Cells)

Snippet

Sponsor: Houssam Farres, M.D. | Conditions: End Stage Renal Disease | Phase 1 | Status: RECRUITING